• Biome achieves 41% growth in quarterly sales revenue to ~$4.5m
• Financial year to date sales revenue reaches ~$13.4m, up 46% vs PCP
• Same-store-sales grow 45% over the last 3 months vs PCP
• Biome awarded Terry White Chemmart's retail supplier of the year

Biome Australia Limited (ASX: BIO), a microbiome health company, has reported a strong trading update for Q3 FY25. The company's quarterly sales revenue totaled $4.5m (unaudited), representing a 41% growth compared to the previous corresponding quarter (Q3 FY24). This result, along with the record quarter in Q2, sets Biome up well to close out FY25. The growth through the first nine months represents a 46% increase versus the prior corresponding period. Same-store-sales, a key metric to present the underlying growth of the business, was up 45% through December to February versus the prior corresponding period. This result highlights Biome's ability to develop its existing business as a core driver to the recent growth in sales revenue. Despite the Q3 period being the seasonally slowest quarter due to reduced trading days and school holidays, Biome has maintained a compounded annual growth rate of 70% over the rolling three years to March 30. Biome was also awarded the coveted retail supplier of the year award by Terry White Chemmart (TWCM), Australia's largest pharmacy group and leader in community pharmacy. This recognition reinforces the strong sales growth and service Biome's team is delivering in the community pharmacy industry. Biome expects to report its fifth consecutive quarter of positive EBITDA when it releases its upcoming appendix 4C later this month.

Biome expects to report another quarter of positive EBITDA for Q3 FY25.

As Biome enters the June quarter, the company and its Activated Probiotics brand are well positioned for significant growth to close the financial year, aiming for its first full year of net profit. During Q4, there will be a number of new product launches and new customers commencing trading both locally and abroad.